Published in BMC Biotechnol on April 26, 2012
Plant-based vaccines against viruses. Virol J (2014) 0.95
Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge. Hum Vaccin Immunother (2013) 0.87
Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique. PLoS One (2013) 0.84
Production of the Main Celiac Disease Autoantigen by Transient Expression in Nicotiana benthamiana. Front Plant Sci (2015) 0.79
Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity. PLoS One (2014) 0.77
Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine. Front Bioeng Biotechnol (2015) 0.76
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B. Int J Mol Sci (2016) 0.75
From plant virology to vaccinology: The road less travelled. Hum Vaccin Immunother (2015) 0.75
Metabolomics, Standards, and Metabolic Modeling for Synthetic Biology in Plants. Front Bioeng Biotechnol (2015) 0.75
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) (1972) 7.42
The ferret: an animal model to study influenza virus. Lab Anim (NY) (2004) 3.75
Avian influenza A (H5N1): a preliminary review. Indian J Med Microbiol (2007) 1.73
Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus. FEBS Lett (2002) 1.66
The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J (2010) 1.57
Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine (2008) 1.41
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One (2010) 1.40
Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin (2011) 1.38
Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J (2008) 1.34
A global pandemic influenza vaccine action plan. Vaccine (2006) 1.31
Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol (2007) 1.25
Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol (2004) 1.24
Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine (2008) 1.16
Plant-produced vaccines: promise and reality. Drug Discov Today (2008) 1.11
A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses (2008) 1.07
Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol (2008) 1.02
NEW technologies for meeting the global demand for pandemic influenza vaccines. Biologicals (2008) 0.97
Immunological assessment of plant-derived avian flu H5/HA1 variants. Vaccine (2009) 0.85
Third International Conference on Plant-Based Vaccines and Antibodies. Expert Rev Vaccines (2009) 0.80
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One (2013) 1.83
Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol (2008) 1.62
Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis (2012) 1.61
Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis (2008) 1.61
HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer (2006) 1.54
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52
Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis (2009) 1.50
Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J Virol (2008) 1.31
Twenty-five years of outpatient influenza surveillance in South Africa, 1984-2008. J Infect Dis (2012) 1.31
The evolutionary value of recombination is constrained by genome modularity. PLoS Genet (2005) 1.26
Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer (2009) 1.23
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol (2005) 1.22
Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology (2009) 1.21
Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Acta Cytol (2009) 1.20
A proposal to change existing virus species names to non-Latinized binomials. Arch Virol (2010) 1.18
Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology (2004) 1.16
Recombination, decreased host specificity and increased mobility may have driven the emergence of maize streak virus as an agricultural pathogen. J Gen Virol (2008) 1.12
High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol (2003) 1.12
Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol (2007) 1.12
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. J Virol (2003) 1.11
Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial. J Gen Virol (2006) 1.10
Oral immunogenicity of human papillomavirus-like particles expressed in potato. J Virol (2003) 1.09
Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits. Virol J (2012) 1.08
Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Cancer Causes Control (2003) 1.08
Two methods of self-sampling compared to clinician sampling to detect reproductive tract infections in Gugulethu, South Africa. Sex Transm Dis (2006) 1.07
The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. Virus Res (2006) 1.07
Evidence of unique genotypes of beak and feather disease virus in southern Africa. J Virol (2004) 1.06
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology (2005) 1.06
Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding. J Infect Dis (2011) 1.06
Insights into the role and function of L2, the minor capsid protein of papillomaviruses. Arch Virol (2009) 1.05
Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies. J Clin Microbiol (2007) 1.05
A protocol for the rapid isolation of full geminivirus genomes from dried plant tissue. J Virol Methods (2008) 1.05
Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C. AIDS Res Hum Retroviruses (2008) 1.05
More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis (2006) 1.03
The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer (2007) 1.03
Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol (2008) 1.02
Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine (2005) 1.02
The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods (2002) 1.01
Evidence of ancient papillomavirus recombination. J Gen Virol (2006) 1.01
Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol (2008) 1.01
High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J (2009) 1.00
Rapid host adaptation by extensive recombination. J Gen Virol (2009) 1.00
A three-nucleotide mutation altering the Maize streak virus Rep pRBR-interaction motif reduces symptom severity in maize and partially reverts at high frequency without restoring pRBR-Rep binding. J Gen Virol (2005) 0.99
Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b. J Virol (2005) 0.99
Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. J Gen Virol (2010) 0.99
The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection. Antivir Ther (2011) 0.98
Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer. J Med Virol (2003) 0.98
Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology (2006) 0.98
Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference. Eur J Immunol (2007) 0.98
Genetic analysis of maize streak virus isolates from Uganda reveals widespread distribution of a recombinant variant. J Gen Virol (2007) 0.98
Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Res (2006) 0.97
Experimental evidence indicating that mastreviruses probably did not co-diverge with their hosts. Virol J (2009) 0.97
High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers. Infect Dis Obstet Gynecol (2011) 0.96
A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J (2013) 0.96
Experimental observations of rapid Maize streak virus evolution reveal a strand-specific nucleotide substitution bias. Virol J (2008) 0.96
Restoration of native folding of single-stranded DNA sequences through reverse mutations: an indication of a new epigenetic mechanism. Arch Biochem Biophys (2006) 0.95
Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J Infect Dis (2012) 0.95
Determinants of sexual activity and its relation to cervical cancer risk among South African women. BMC Public Health (2007) 0.94
Human papillomavirus vaccines in plants. Expert Rev Vaccines (2010) 0.93
Reconstructing the history of maize streak virus strain a dispersal to reveal diversification hot spots and its origin in southern Africa. J Virol (2011) 0.93
Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses (2015) 0.93
The use of transient expression systems for the rapid production of virus-like particles in plants. Curr Pharm Des (2013) 0.92
Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women. J Clin Microbiol (2007) 0.92
The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer (2006) 0.92
Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon. Tuberculosis (Edinb) (2007) 0.92
An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice. Gut Pathog (2009) 0.92
Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax. Antimicrob Agents Chemother (2010) 0.91
Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix. Acta Obstet Gynecol Scand (2003) 0.91
A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice. AIDS Res Hum Retroviruses (2008) 0.90
Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol (2005) 0.90
Phylogenetic and histological variation in avipoxviruses isolated in South Africa. J Gen Virol (2013) 0.90
Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells. PLoS One (2012) 0.90
Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. Curr HIV Res (2010) 0.90
The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples. J Infect (2013) 0.90
Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation. J Infect Dis (2013) 0.90
Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice. J Gen Virol (2004) 0.89
Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice. Virol J (2009) 0.89
Dating the origins of the maize-adapted strain of maize streak virus, MSV-A. J Gen Virol (2009) 0.89
Papanicolaou smears and cervical inflammatory cytokine responses. J Inflamm (Lond) (2007) 0.89
Maize streak virus-resistant transgenic maize: a first for Africa. Plant Biotechnol J (2007) 0.88
Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans. BMC Res Notes (2009) 0.88
Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. Virus Res (2008) 0.88
Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons. J Gen Virol (2009) 0.88
CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women. BMC Cancer (2010) 0.87
Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV. J Med Virol (2002) 0.87
Maize streak virus: an old and complex 'emerging' pathogen. Mol Plant Pathol (2010) 0.87